Funding
Funding not disclosed
Founders
Product
Problem
Individuals seeking to optimize their health and longevity often face challenges in accessing personalized and data-driven regenerative therapies. Traditional healthcare approaches may not adequately address individual needs with targeted interventions, leading to suboptimal outcomes in cellular repair, energy levels, and overall well-being.
Solution
Dripdok provides at-home regenerative medicine and IV therapy services, delivering personalized treatments based on individual biometric data and advanced testing. By leveraging a proprietary CLOSE Regenerative Index, Dripdok tracks and analyzes patient progress, ensuring measurable results in cellular regeneration and overall healthspan. Their approach combines cutting-edge therapies, including NAD+, NMN, exosomes, and peptides, with data-driven insights to optimize protocols for each patient's unique needs. Dripdok aims to redefine healthcare by making personalized regenerative care accessible and effective, focusing on reversing degeneration and building cellular resilience.
Target Audience
Dripdok primarily targets individuals seeking advanced, personalized regenerative medicine to optimize their healthspan, including executives, athletes, and those looking to improve energy levels, cognitive function, and overall well-being.
Features
- At-home IV therapy administration for convenience and comfort
- Personalized treatment plans based on individual biometric data and advanced testing
- Proprietary CLOSE Regenerative Index for tracking and measuring treatment progress
- Wide range of regenerative therapies, including NAD+, NMN, exosomes, and peptides
- USP-grade IV compounds for superior results and safety
- Data-driven consultations for tailored peptide optimization, TRT, and longevity planning
- Mobile NAD+ IV treatments and functional wellness IVs
- Option for house calls and prescription services